A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

Understanding patient personas could lead to better treatment adherence, experiences, and outcomes

by Dr. Bruce Green, managing director and chief medical officer, federal practice, Deloitte Consulting LLP; and Jessica Nadler, senior manager, Deloitte Consulting LLP

Understanding patient attitudes and preferences within the context of the patient journey can be central to supporting healthy behaviors and better health outcomes. To improve treatment adherence, health systems and clinicians should know their patient populations beyond demographic and disease information. They should consider getting to know what drives patient decision-making.

Patients are more than their disease—they are people with families and jobs,

Read more

Digitizing life sciences R&D, one step at a time

by Dawn Anderson, Managing director, Deloitte Consulting LLP

For a life sciences industry whose Research & Development (R&D) processes are often held over from the 1990s—and whose returns on those investments are falling sharply—new digital technologies might feel as if they can’t arrive fast enough.

Almost everywhere you turn, there seems to be an opportunity as outlined in Deloitte’s recent report,

Read more

Digital R&D: Four ways to maximize patient engagement in clinical trials

by Dawn Anderson, Managing director, Deloitte Consulting LLP

The Deloitte Center for Health Solutions recently interviewed 43 biopharmaceutical industry stakeholders to explore where the industry sees value and opportunities for using digital technologies in the clinical development process; understand reasons behind the relatively slow pace of digital adoption; and uncover strategies to overcome barriers and accelerate the use of digital in clinical trials.

Read more

Five barriers that could keep biosimilar manufacturers from cracking the US market

by James Forsyth, Director, Deloitte MCS Limited, and Cameron McClearn, Principal, Deloitte Consulting LLP

The biosimilars market in the US has lagged well behind the European market for more than a decade.1 While a recent push from the White House could help expand the use of biosimilars in the US, manufacturers could still face some significant challenges there.

In April, the administration released its “blueprint” for lowering drug prices and reducing out-of-pocket costs for US consumers.

Read more

The next generation of scientists are digital natives ready to problem solve and innovate

by Juergen A. Klenk, Ph.D, Principal, Deloitte Consulting LLP

This week Deloitte and the National Institutes of Health’s National Library of Medicine (NLM) will recognize two student-led research teams from San Diego State University (SDSU) and Kingsborough Community College of The City University of New York (KCC CUNY) for their groundbreaking research in the Microbial Metagenomics Discovery Challenge.

The undergraduate students’ work was impressive by any standard.

Read more

From center ice to the operating room: AR/VR technologies could transform consumer, clinician, and patient experiences

by Shantaram (Shaun) Rangappa, MD, MSHA, Managing Director, Deloitte Consulting LLP

I live outside of Washington, D.C., and I was thrilled to see the Washington Capitals advance to the Stanley Cup finals for the first time in 20 years. I always enjoy watching sports on TV, but the experience has changed little since sports became televised. Now imagine donning an immersive experience headset and watching a championship game from center ice…with players gliding all around you.

Read more